Company: INVUP
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022223
Chunk: 86

Company: Investview, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 86
---
 at the closing of the loan.

The
loans referenced in footnotes 1-3 above were advanced under a Securities Purchase Agreement we entered into on April 27, 2020, with DBR
Capital. Under the Securities Purchase Agreement (which was subsequently amended and restated), DBR Capital agreed to advance up to $11
million to us in a series of up to five closings through December 31, 2026, of which the amounts advanced covered in footnotes 1-3 above
constituted the first three closings.

On
February 28, 2025, we and DBR Capital entered into a Fifth Amendment to the now Amended and Restated Securities Purchase Agreement that
extends the deadlines for the fourth and fifth closings under that Agreement from December 31, 2024, to August 31, 2025, and December
31, 2026, respectively. Accordingly, DBR Capital’s right to effect the fourth closing expired on August 31, 2205; however, the
fifth closing remains at the sole discretion of DBR Capital, and we cannot provide any assurance that it will occur when contemplated
or ever.

Other
Related Party Arrangements

On
September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase
and Release Agreement dated September 18, 2023 (the “Romano/Raynor Agreement”). Under the Romano/Raynor Agreement, the Company
purchased for surrender in a series of private transactions, an aggregate of 302,919,223 shares of the Company’s common stock (the
“Romano/Raynor Purchased Shares”) from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members
and related entities (collectively, the “Sellers”). The Romano/Raynor Purchased Shares were purchased for aggregate consideration
of $2,922,380, representing a price of $0.00964739 per share. One-eighth of the purchase price was paid within seven (7) days of the
closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of September
30, 2025, we owed $0 under the Romano/Raynor Agreement.

In
addition to the cash consideration for the Purchased Shares, the Company also agreed to cover a